Diffuse Spontaneous Laryngeal Hemorrhage with Trastuzumab.

Case Rep Otolaryngol

University of Nebraska Medical Center, Department of Otolaryngology-Head and Neck Surgery, 981225 Nebraska Medical Center, Omaha, Nebraska 68198-1225, USA.

Published: August 2020

Drug-induced epithelial hemorrhage of the endolarynx is an unusual etiology of hemoptysis. We present a case of hemoptysis in a young female patient undergoing treatment for metastatic breast cancer with trastuzumab emtansine. Though previously associated with diffuse spontaneous hemorrhage of the gingiva, there have not been reports of laryngeal hemorrhage with trastuzumab emtansine treatment. In this case report, we suggest that trastuzumab emtansine played a contributory role in the development of diffuse epithelial laryngeal hemorrhage and describe the pathophysiology, history, laryngoscopic findings, and management of this condition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463383PMC
http://dx.doi.org/10.1155/2020/8818905DOI Listing

Publication Analysis

Top Keywords

laryngeal hemorrhage
12
trastuzumab emtansine
12
diffuse spontaneous
8
hemorrhage trastuzumab
8
hemorrhage
5
spontaneous laryngeal
4
trastuzumab
4
trastuzumab drug-induced
4
drug-induced epithelial
4
epithelial hemorrhage
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!